Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
134
Frequently Asked Questions
What is Market Cap of Inovio Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Inovio Pharmaceuticals Inc market cap is $148.27M.
What is the 52-week high for Inovio Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Inovio Pharmaceuticals Inc 52 week high is $7.00 as of September 06, 2025.
What is the 52-week low for Inovio Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Inovio Pharmaceuticals Inc 52 week low is $1.30 as of September 06, 2025.
What is Inovio Pharmaceuticals Inc stock price today?
Inovio Pharmaceuticals Inc stock price today is $2.79.
What was Inovio Pharmaceuticals Inc stock price yesterday?
Inovio Pharmaceuticals Inc stock price yesterday was $2.75.
What is the PE ratio of Inovio Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Inovio Pharmaceuticals Inc’s P/E ratio is -1.07.
What is the Price-to-Book ratio of Inovio Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Inovio Pharmaceuticals Inc P/B ratio is 3.5906.
What is the 50-day moving average of Inovio Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Inovio Pharmaceuticals Inc 50-day moving average is $1.74.
How many employess does Inovio Pharmaceuticals Inc has?